Braddock Demetrios

Historial de resultados de Braddock Demetrios

Historial insuficiente para un historial de resultados estadístico (menos de 5 compras en el mercado).

Historial de operaciones de Braddock Demetrios

Co-iniciados de Braddock Demetrios

• ALEXION PHARMACEUTICALS INCInozyme Pharma, Inc.
• BASKETT FORESTInozyme Pharma, Inc.
• Basso StephenInozyme Pharma, Inc.
• Bhagat Sarah MInozyme Pharma, Inc.
• Bjarke Henric BjornInozyme Pharma, Inc.
• Bolte AxelInozyme Pharma, Inc.
• DIAZ REINALDO MInozyme Pharma, Inc.
• DiPalma Stephen J.Inozyme Pharma, Inc.
• Edwards MartinInozyme Pharma, Inc.
• ENRIGHT PATRICK GInozyme Pharma, Inc.
• Florence Anthony A. Jr.Inozyme Pharma, Inc.
• Harris ErikInozyme Pharma, Inc.
• HEALY JAMESInozyme Pharma, Inc.
• Hopfner Robert LorneInozyme Pharma, Inc.
• Huertas PedroInozyme Pharma, Inc.
• Inozyme Pharma, Inc.Inozyme Pharma, Inc.
• Jungles Steven JInozyme Pharma, Inc.
• Katabi MahaInozyme Pharma, Inc.
• Kolchinsky PeterInozyme Pharma, Inc.
• Longitude Capital Partners III, LLCInozyme Pharma, Inc.
• Longitude Venture Partners III, L.P.Inozyme Pharma, Inc.
• Makhzoumi MohamadInozyme Pharma, Inc.
• MAKOWER JOSHUAInozyme Pharma, Inc.
• Mathers Edward TInozyme Pharma, Inc.
• NEA 15 GP, LLCInozyme Pharma, Inc.
• NEA Partners 15, L.P.Inozyme Pharma, Inc.
• New Enterprise Associates 15, L.P.Inozyme Pharma, Inc.
• Novo A/SInozyme Pharma, Inc.
• Pivotal bioVenture Partners Fund I G.P., L.P.Inozyme Pharma, Inc.
• Pivotal bioVenture Partners Fund I, L.P.Inozyme Pharma, Inc.
• Pivotal bioVenture Partners Fund I U.G.P., LtdInozyme Pharma, Inc.
• POWELL MICHAELInozyme Pharma, Inc.
• RA CAPITAL MANAGEMENT, LLCInozyme Pharma, Inc.
• Rock Springs Capital LLCInozyme Pharma, Inc.
• Rock Springs Capital Management LPInozyme Pharma, Inc.
• Rock Springs Capital Master Fund LPInozyme Pharma, Inc.
• SANDELL SCOTT DInozyme Pharma, Inc.
• SANOFI-AVENTISInozyme Pharma, Inc.
• Schlessinger JosephInozyme Pharma, Inc.
• Shah Rajeev M.Inozyme Pharma, Inc.
• Sofinnova Management X, L.L.C.Inozyme Pharma, Inc.